These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36815757)

  • 21. Inclusion body myositis: a case of bilateral extremity weakness.
    Lam L; Scheper S; Zagorski N; Chung M; Noguchi H; Liow KK
    Hawaii J Med Public Health; 2013 Dec; 72(12):417-20. PubMed ID: 24377075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myofibrillar myopathy caused by a novel FHL1 mutation presenting a mild myopathy with ankle contracture.
    Park YE; Kim DS; Shin JH
    Clin Neurol Neurosurg; 2019 May; 180():48-51. PubMed ID: 30928807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mutation in the N-terminal acting-binding domain of Filamin C protein causing a distal myofibrillar myopathy.
    Gemelli C; Prada V; Fiorillo C; Fabbri S; Maggi L; Geroldi A; Gibertini S; Mandich P; Trevisan L; Fossa P; Tagliafico AS; Schenone A; Grandis M
    J Neurol Sci; 2019 Mar; 398():75-78. PubMed ID: 30685713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [PM-Scl antibody positive systemic sclerosis associated with inclusion-body myositis].
    Kim S; Genth E; Krieg T; Hunzelmann N
    Z Rheumatol; 2005 Oct; 64(7):499-502. PubMed ID: 16244833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptome analysis from muscle biopsy tissues in late-onset myopathies identifies potential biomarkers correlating to muscle pathology.
    Joel MM; Pontifex C; Martens K; Chhibber S; de Koning J; Pfeffer G
    Neuromuscul Disord; 2022 Aug; 32(8):643-653. PubMed ID: 35850946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia.
    Mehta SG; Khare M; Ramani R; Watts GD; Simon M; Osann KE; Donkervoort S; Dec E; Nalbandian A; Platt J; Pasquali M; Wang A; Mozaffar T; Smith CD; Kimonis VE
    Clin Genet; 2013 May; 83(5):422-31. PubMed ID: 22909335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distal myopathy with rimmed vacuoles and hereditary inclusion body myopathy.
    Nonaka I; Noguchi S; Nishino I
    Curr Neurol Neurosci Rep; 2005 Feb; 5(1):61-5. PubMed ID: 15676110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial abnormalities in the myofibrillar myopathies.
    Jackson S; Schaefer J; Meinhardt M; Reichmann H
    Eur J Neurol; 2015 Nov; 22(11):1429-35. PubMed ID: 26204918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sporadic Inclusion Body Myositis and Other Rimmed Vacuolar Myopathies.
    Weihl CC
    Continuum (Minneap Minn); 2019 Dec; 25(6):1586-1598. PubMed ID: 31794461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C and inclusion body myositis.
    Alexander JA; Huebner CJ
    Am J Gastroenterol; 1996 Sep; 91(9):1845-7. PubMed ID: 8792712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inclusion body myositis: clinical and pathological boundaries.
    Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
    Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI for Evaluation of Flexor Digitorum Profundus Muscle Involvement in Inclusion Body Myositis.
    Inaishi Y; Fukumoto M; Koide R; Kondo K; Nakata Y; Nakano I
    Can J Neurol Sci; 2014 Nov; 41(6):780-1. PubMed ID: 26693542
    [No Abstract]   [Full Text] [Related]  

  • 33. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis.
    Askanas V; Engel WK
    Curr Opin Rheumatol; 1998 Nov; 10(6):530-42. PubMed ID: 9812213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel nonsense mutation in the dimerization domain of FLNC causing mild myofibrillar myopathy.
    Park YE; Kim DS; Shin JH
    Clin Neurol Neurosurg; 2022 Oct; 221():107386. PubMed ID: 35961230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inclusion body myositis: atypical clinical presentations.
    Schlesinger I; Soffer D; Lossos A; Meiner Z; Argov Z
    Eur Neurol; 1996; 36(2):89-93. PubMed ID: 8654492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential Diagnoses of Inclusion Body Myositis.
    Vivekanandam V; Bugiardini E; Merve A; Parton M; Morrow JM; Hanna MG; Machado PM
    Neurol Clin; 2020 Aug; 38(3):697-710. PubMed ID: 32703477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sporadic Inclusion Body Myositis Manifesting as Isolated Muscle Weakness of the Finger Flexors Three Years after Disease Onset.
    Suwa Y; Suzuki N; Soga T; Harada R; Shibui A; Kuroda H; Izumi R; Tateyama M; Nakashima I; Sonoo M; Aoki M
    Intern Med; 2016; 55(23):3521-3524. PubMed ID: 27904121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
    Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TDP-43 plasma levels do not differentiate sporadic inclusion body myositis from other inflammatory myopathies.
    Kuiperij HB; Abdo WF; van Engelen BG; Schelhaas HJ; Verbeek MM
    Acta Neuropathol; 2010 Dec; 120(6):825-6. PubMed ID: 21046407
    [No Abstract]   [Full Text] [Related]  

  • 40. Camptocormia due to inclusion body myositis.
    Goodman BP; Liewluck T; Crum BA; Spinner RJ
    J Clin Neuromuscul Dis; 2012 Dec; 14(2):78-81. PubMed ID: 23172388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.